LDN MS Treatment

Low Dose Naltrexone: Multiple Sclerosis Treatment Option

The following study was conducted over 6 months on 40 patients with Primary Progressive Multiple Sclerosis (PPMS).

The study concluded that symptoms such as spasticity, pain, fatigue, depression, and quality of life improved in 39 of the 40 patients followed.

Click Here to read more.